7 interesting healthcare stocks for long-term investment
From pharmaceutical companies to biotech innovators, these companies are bringing modern and effective solutions to the healthcare industry, and companies in this sector are likely to be profitable for years to come.
At a time when the economy is subject to uncertainty, it is advisable to focus on sectors that can withstand market fluctuations. The healthcare sector appears to be stable and attractive for investment as people continue to place a premium on their overall health.
Illumina $ILMN-0.6%
Illumina, a cutting-edge biotechnology company that manufactures and sells systems for the analysis of genetic and biological functions. Although the stock has shownvolatility over the past year, this market likely offers tremendous upside potential. With this market expected to grow to $83.1 billion by 2028, Illumina represents an exciting investment opportunity.
Illumina
ILMNHologic $HOLX+0.0%
Hologic, a medical technologycompany focused on women's health, provides diagnostic and surgical solutions. With an expected global market growth to $34.6 billion by 2030, Hologic has the potential to see significant growth.
Hologic
HOLXJohnson & Johnson $JNJ-0.2%
Johnson & Johnson Focuses on pharmaceutical and medical technology. With a global medical device market worth $799 billion by 2030 and a pharmaceutical market reaching $2.8 trillion, JNJ remains one of the most important healthcare stocks.
Modern $MRNA-3.4%
Moderna, known for its role in the development of the Covid-19 vaccine, is moving into new innovations. With the global cancer vaccine market projected to grow to $16.84 billion, Moderna may offer exciting investment opportunities.
Moderna
MRNAEditas Medicine $EDIT-0.9%
Editas Medicine, which deals with therapies for rare diseases using special technology, represents a riskier but innovative investment. Thus Editas Medicine may be attractive to investors with a higher appetite for risk.
Verve Therapeutics $VERV-3.5%
Company Verve Therapeutics focuses on protecting against cardiovascular disease using "gene circuit" technology. With the global market expected to grow to $5.78 billion by 2030, VERV may represent a unique investment opportunity.
Intellia Therapeutics $NTLA-1.7%
Company Intellia Therapeutics has become a pioneer in the field of gene therapy using revolutionary technologies. The company focuses on treating genetic diseases using special technologies. With the rapid development of this field and increasing awareness of the potential of gene therapy, Intellia Therapeutics offers an investment opportunity in an area with tremendous innovation potential.
Disclaimer: There is a lot of inspiration to be found on Bulios, however, stock selection and portfolio construction is entirely up to you, so always conduct thorough self-analysis.
Source.